Journal article
Efficacy and Safety of Fixed Low-Dose Dalteparin in Preventing Venous Thromboembolism Among Obese or Elderly Hospitalized Patients: A Subgroup Analysis of the PREVENT Trial
Abstract
BACKGROUND: We were concerned that a fixed rather than a weight-based dosing regimen of dalteparin sodium to prevent venous thromboembolism (VTE) might result in decreased efficacy in obese patients and decreased safety in elderly patients.
METHODS: We retrospectively performed subgroup analyses using the database from the Prospective Evaluation of Dalteparin Efficacy for Prevention of VTE in Immobilized Patients (PREVENT) Trial, a study of …
Authors
Kucher N; Leizorovicz A; Vaitkus PT; Cohen AT; Turpie AGG; Olsson C-G; Goldhaber SZ
Journal
JAMA Internal Medicine, Vol. 165, No. 3, pp. 341–345
Publisher
American Medical Association (AMA)
Publication Date
February 14, 2005
DOI
10.1001/archinte.165.3.341
ISSN
2168-6106